RGene Therapeutics Inc., Pasteur Merieux-Connaught deal

Pasteur Merieux-Connaught will obtain an exclusive license to use RGene's cationic lipid DC-Cholesterol as an immunoadjuvant in traditional vaccines. The agreement provides for upfront and milestone fees, and royalties on sales. ...